Previous Statements by FOLD
» Amicus Therapeutics CEO Discusses Q3 2010 Results - Earnings Call Transcript
» Amicus Therapeutics Agreement with GSK - Call Transcript
» Amicus Therapeutics, Inc. Q2 2010 Earnings Call Transcript
Teligent, FibroGen and Amicus Therapeutics were among the biotech stock movers in premarket trading on July 21.
Big gains could be ahead for investors willing to stick with the stock, according to one firm.